These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24255116)

  • 1. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants.
    Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
    Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).
    Gagné JF; Montminy V; Belanger P; Journault K; Gaucher G; Guillemette C
    Mol Pharmacol; 2002 Sep; 62(3):608-17. PubMed ID: 12181437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
    Malfatti MA; Felton JS
    Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4.
    Takeda S; Ishii Y; Iwanaga M; Mackenzie PI; Nagata K; Yamazoe Y; Oguri K; Yamada H
    Mol Pharmacol; 2005 Mar; 67(3):665-72. PubMed ID: 15611481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
    Lankisch TO; Schulz C; Zwingers T; Erichsen TJ; Manns MP; Heinemann V; Strassburg CP
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):695-701. PubMed ID: 18349289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.
    Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H
    Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.
    Jinno H; Saeki M; Saito Y; Tanaka-Kagawa T; Hanioka N; Sai K; Kaniwa N; Ando M; Shirao K; Minami H; Ohtsu A; Yoshida T; Saijo N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2003 Aug; 306(2):688-93. PubMed ID: 12730278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4.
    Fremont JJ; Wang RW; King CD
    Mol Pharmacol; 2005 Jan; 67(1):260-2. PubMed ID: 15486048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the rabbit liver UDP-glucuronosyltransferase catalyzing the glucuronidation of 4-ethoxyphenylurea (dulcin).
    Uesawa Y; Staines AG; O'Sullivan A; Mohri K; Burchell B
    Drug Metab Dispos; 2004 Dec; 32(12):1476-81. PubMed ID: 15448114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms.
    Fujiwara R; Nakajima M; Yamanaka H; Nakamura A; Katoh M; Ikushiro S; Sakaki T; Yokoi T
    Drug Metab Dispos; 2007 May; 35(5):747-57. PubMed ID: 17293379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UDP-Glucuronosyltransferase (UGT)-mediated attenuations of cytochrome P450 3A4 activity: UGT isoform-dependent mechanism of suppression.
    Miyauchi Y; Tanaka Y; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H; Ishii Y
    Br J Pharmacol; 2020 Mar; 177(5):1077-1089. PubMed ID: 31660580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.
    Jinno H; Tanaka-Kagawa T; Hanioka N; Saeki M; Ishida S; Nishimura T; Ando M; Saito Y; Ozawa S; Sawada J
    Drug Metab Dispos; 2003 Jan; 31(1):108-13. PubMed ID: 12485959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
    Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Kinetic Characterization of Axitinib Metabolism.
    Zientek MA; Goosen TC; Tseng E; Lin J; Bauman JN; Walker GS; Kang P; Jiang Y; Freiwald S; Neul D; Smith BJ
    Drug Metab Dispos; 2016 Jan; 44(1):102-14. PubMed ID: 26512042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of common genetic variants of human uridine diphosphate glucuronosyltransferase subfamilies on irinotecan glucuronidation.
    Tagawa K; Maruo Y; Mimura Y; Ikushiro S
    Toxicol Mech Methods; 2023 Mar; 33(3):197-205. PubMed ID: 35930428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases.
    Bachrich T; Thalhammer T; Jäger W; Haslmayer P; Alihodzic B; Bakos S; Hitchman E; Senderowicz AM; Penner E
    Hepatology; 2001 May; 33(5):1053-9. PubMed ID: 11343231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid.
    Miles KK; Kessler FK; Smith PC; Ritter JK
    Drug Metab Dispos; 2006 Sep; 34(9):1632-9. PubMed ID: 16790558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.